COST

924.4

+0.57%↑

147.99

-0.05%↓

70.94

-0.76%↓

154.04

-0.76%↓

PEP

145.37

-0.38%↓

COST

924.4

+0.57%↑

147.99

-0.05%↓

70.94

-0.76%↓

154.04

-0.76%↓

PEP

145.37

-0.38%↓

COST

924.4

+0.57%↑

147.99

-0.05%↓

70.94

-0.76%↓

154.04

-0.76%↓

PEP

145.37

-0.38%↓

COST

924.4

+0.57%↑

147.99

-0.05%↓

70.94

-0.76%↓

154.04

-0.76%↓

PEP

145.37

-0.38%↓

COST

924.4

+0.57%↑

147.99

-0.05%↓

70.94

-0.76%↓

154.04

-0.76%↓

PEP

145.37

-0.38%↓

Начало・Списък с акции・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Отворен

СекторДефанзивни потребителски стоки

7.88 -0.76

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

7.48

Максимум

7.98

Ключови измерители
By Trading Economics
Приходи	13M -2M
Продажби	1.3M 36M
EPS	-0.253
Марж на печалбата	-5.617
Служители	406

Пазарни показатели
By TradingEconomics
Пазарна капитализация	15M 241M
Предишно отваряне	8.64
Предишно затваряне	7.88

Настроения в новините

By Acuity

50%

67 / 148 Класиране в Consumer defensive

Lifecore Biomedical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.11.2025 г., 21:34 ч. UTC

Печалби

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13.11.2025 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13.11.2025 г., 23:42 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13.11.2025 г., 23:41 ч. UTC

Пазарно говорене

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13.11.2025 г., 23:24 ч. UTC

Печалби

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13.11.2025 г., 23:24 ч. UTC

Печалби

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13.11.2025 г., 23:23 ч. UTC

Печалби

JBS NV 3Q EPS 52c >JBS

13.11.2025 г., 23:23 ч. UTC

Печалби

JBS NV 3Q Sales $22.6B >JBS

13.11.2025 г., 23:04 ч. UTC

Пазарно говорене

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13.11.2025 г., 22:02 ч. UTC

Печалби

Nu Holdings 3Q Net $783M >NU

13.11.2025 г., 22:01 ч. UTC

Печалби

Nu Holdings 3Q Rev $4.2B >NU

13.11.2025 г., 21:51 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13.11.2025 г., 21:50 ч. UTC

Печалби

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13.11.2025 г., 21:45 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13.11.2025 г., 21:41 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13.11.2025 г., 21:33 ч. UTC

Пазарно говорене

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13.11.2025 г., 21:33 ч. UTC

Печалби

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13.11.2025 г., 21:31 ч. UTC

Печалби

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13.11.2025 г., 21:25 ч. UTC

Печалби

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13.11.2025 г., 21:25 ч. UTC

Печалби

Figure Tech Solutions 3Q EPS 34c >FIGR

13.11.2025 г., 21:23 ч. UTC

Печалби

Intchains Group 3Q Rev $1.3M >ICG

13.11.2025 г., 21:03 ч. UTC

Печалби

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13.11.2025 г., 21:02 ч. UTC

Печалби

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13.11.2025 г., 21:01 ч. UTC

Печалби

Applied Materials 4Q Rev $6.8B >AMAT

13.11.2025 г., 21:01 ч. UTC

Печалби

Applied Materials 4Q Gross Margin 48.0% >AMAT

Сравнение с други в отрасъла

Ценова промяна

Lifecore Biomedical Inc Прогноза

Консенсусна оценка

By TipRanks

Купи

4 ratings

Купи

Задържане

Продай

Според 4 анализатори, дали борсови рейтинги на Lifecore Biomedical Inc през последните 3 месеца.

Настроение

By Acuity

67 / 148 Класиране в Дефанзивни потребителски стоки

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.